Home/ Supplements/ Saw Palmetto/ Saw Palmetto & Pygeum

Saw Palmetto & Pygeum

product on market Capsule Absorb Health Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Saw palmetto and pygeum are studied for their potential to support prostate health and urinary function. Research provides moderate evidence that these ingredients may help reduce symptoms of benign prostatic hyperplasia. However, overall evidence coverage for this specific formulation remains limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Saw Palmetto & Pygeum
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
Botanical
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Pygeum
100 mg
320 mg
Market median: 320.0mg (426 products) 26 studies (A:0, B:5)

Other Ingredients

Gelatin Microcrystalline Cellulose Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Warnings & Precautions

Warning: If you are pregnant, nursing, taking any medications or have any medical condition, consult your doctor before use.

Discontinue use and consult your doctor if any adverse reactions occur.

Keep out of the reach of children.

Do not use if seal under cap is broken or missing.

Formulation Notes

Prostate support

No cutting agents

Additional Information

Store at room temperature with lid tightly closed.

Shop at www.absorbyourhealth.com for all your mind, body, and spirit needs.

Metadata

Product Details

UPC / SKU7 90566 99127 9
DSLD Entry Date2020-03-24
Product TypeBotanical
FormCapsule
DSLD ID216040
Data Updated2026-04-11
Research

Research Evidence

35
Research Sources
52
Avg Quality
15
Meta Analysis
11
Systematic Review
7
Rct
1
Narrative Review
1
Openfda Safety
B Serenoa repens for benign prostatic hyperplasia
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
B Serenoa repens for benign prostatic hyperplasia
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
B Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis
Meta Analysis Investigative and clinical urology 2021 PubMed DOI
B Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials
Systematic Review European urology focus 2021 PubMed DOI
B Non-hormonal treatment for male infertility: the potential role of Serenoa repens, selenium and lycopene
Systematic Review European review for medical and pharmacological sciences 2019 PubMed DOI
B Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
Meta Analysis American journal of men's health 2020 PubMed DOI
B Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review
Systematic Review BJU international 2012 PubMed DOI
B Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis
Systematic Review Frontiers in nutrition 2025 PubMed DOI
C Benign prostate hyperplasia and nutrition
Systematic Review Clinical nutrition ESPEN 2019 PubMed DOI
C American palm ethnomedicine: a meta-analysis
Meta Analysis Journal of ethnobiology and ethnomedicine 2009 PubMed DOI
View all evidence for Saw Palmetto →
Compare

Similar Products

View all Saw Palmetto products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.